Scythian Biosciences Corp Share Price Canadian Securities Exchange
Equities
CA7840531007
Investment Management & Fund Operators
Sales 2022 | -235.54 -321.68 -19.64K | Sales 2023 | -31.51 -43.04 -2.63K | Capitalization | 6.26M 8.55M 522M |
---|---|---|---|---|---|
Net income 2022 | -297M -406M -24.76B | Net income 2023 | -34M -46.43M -2.83B | EV / Sales 2022 | -1,88,347 x |
Net Debt 2022 | 24.76M 33.82M 2.06B | Net cash position 2023 | 70.4M 96.14M 5.87B | EV / Sales 2023 | 20,35,264 x |
P/E ratio 2022 |
-0.07
x | P/E ratio 2023 |
-0.18
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 91.99% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Kania
CEO | Chief Executive Officer | - | 19/20/19 |
Deena Siblock
BRD | Director/Board Member | - | 27/23/27 |
Corporate Officer/Principal | - | 17/18/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mehdi Azodi
BRD | Director/Board Member | - | 27/23/27 |
Deena Siblock
BRD | Director/Board Member | - | 27/23/27 |
Jason Batista
BRD | Director/Board Member | - | 07/23/07 |
1st Jan change | Capi. | |
---|---|---|
+3.65% | 31.94B | |
0.00% | 17.45B | |
+6.42% | 5.54B | |
-0.42% | 3.08B | |
+15.23% | 2.98B | |
+22.64% | 2.9B | |
-18.98% | 2.24B | |
+4.02% | 1.23B | |
-2.00% | 1.07B |